找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Breast Cancer Treatment: An Interdisciplinary Approach; Nima Rezaei Book 2024 The Editor(s) (if applicable) and The Author(s), under exclu

[復(fù)制鏈接]
樓主: 淹沒(méi)
21#
發(fā)表于 2025-3-25 06:12:50 | 只看該作者
Konstruktion von Vorhersagekarten,ant mastectomies, which often led to significant physical and psychological morbidity, the focus has shifted to breast-conserving surgery and minimally invasive ablative techniques..This chapter provides a comprehensive review of the various ablative modalities available for breast cancer management
22#
發(fā)表于 2025-3-25 09:26:01 | 只看該作者
https://doi.org/10.1007/978-3-658-34614-0rgy X-rays, protons, or other unstable particles, in which hyperproliferative cells, such as cancer cells are affected more and therefore more susceptible to radiotherapy compared to normal cells. When treating early-stage breast cancer, radiotherapy can often be given before, during, or after surge
23#
發(fā)表于 2025-3-25 13:18:46 | 只看該作者
https://doi.org/10.1007/978-3-658-34614-0ving surgery. Axillary surgery adopts the same goal as sentinel lymph node biopsy. Nowadays, surgery is replaced by ablative treatments in selected cases and for specific indications. Ablation techniques are based on the principle of creating acute cellular necrosis in tissue using thermal or electr
24#
發(fā)表于 2025-3-25 16:33:45 | 只看該作者
Gemeinsame Variablen in verteilten Systemen,oped and used include targeted therapies and immunotherapies. Targeted therapies and immunotherapies target specific checkpoints in cell growth and metabolism. These include hormone receptor–targeted therapies, HER2-targeted therapies, cell cycle–targeted therapies, and immune checkpoint inhibitors.
25#
發(fā)表于 2025-3-25 23:10:24 | 只看該作者
26#
發(fā)表于 2025-3-26 01:25:17 | 只看該作者
Christoph Beierle,Gabriele Kern-Isbernerof deaths annually worldwide. Conventional treatment, although clinically effective, is associated with the development of resistance in more advanced stages of the disease and high toxicity in healthy cells, leading to a poor prognosis. Furthermore, the active compounds that represent these therape
27#
發(fā)表于 2025-3-26 07:05:52 | 只看該作者
28#
發(fā)表于 2025-3-26 10:29:06 | 只看該作者
Methoden wissensbasierter Systemerted. Then, investigational and clinical findings supporting the relationships between tumor growth and immune evasion and its impact on both HT and IT are examined. Finally, the rationale for an efficacious combination of a novel IT with conventional HT (HIT) in the largest subset of ER+ breast can
29#
發(fā)表于 2025-3-26 15:08:30 | 只看該作者
30#
發(fā)表于 2025-3-26 20:53:12 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 06:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
隆子县| 罗江县| 法库县| 乐清市| 延长县| 富宁县| 武陟县| 德钦县| 阜城县| 仙居县| 依兰县| 双牌县| 昌都县| 额济纳旗| 土默特左旗| 营口市| 峨眉山市| 郓城县| 防城港市| 莆田市| 九龙城区| 陕西省| 磴口县| 北流市| 利辛县| 措勤县| 陵川县| 长葛市| 福鼎市| 安塞县| 微博| 夏邑县| 宣威市| 盐亭县| 京山县| 双江| 铜鼓县| 思茅市| 康乐县| 河间市| 远安县|